Bill

Bill > SB1213


MO SB1213

MO SB1213
Enacts requirements for certain reporting regarding the federal 340B drug program


summary

Introduced
01/07/2026
In Committee
01/27/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

Enacts requirements for certain reporting regarding the federal 340B drug program

AI Summary

This bill establishes new reporting requirements for entities participating in the federal 340B Drug Pricing Program (340B program), which helps certain healthcare providers obtain discounted prescription drugs. Specifically, 340B covered entities located in Missouri must submit an annual report to the state Department of Health and Senior Services by April 1st, detailing comprehensive information about their program participation. The required report must include the entity's identifying information, aggregate drug acquisition and payment costs, number of prescription drug claims, how program savings are used (such as for charity care), payments to contract pharmacies and program managers, total operating costs, charity care costs, and a copy of their financial assistance policy. The report must break down data by different payer types like commercial, Medicaid, Medicare, and uninsured. The department will then compile these individual reports into an aggregated electronic report to be shared with the state legislature and published on their website by November 15th. Entities that fail to submit the required information will face a civil penalty of $1,000 per day the report is overdue. The bill aims to increase transparency around how nonprofit and public healthcare providers utilize the 340B drug pricing program to provide affordable healthcare services.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Hearing Conducted S Families, Seniors and Health Committee (on 02/04/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...